FDA

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes INPEFA reduced the risk of total occurrence of cardiovascular death,…

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane…

…

12 of 16 voting-eligible advisors vote “no” (with two…

MORRISTOWN, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Intercept…

• Live demonstration of new software at Heart Rhythm Society…

FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar…

Company on track to complete planned interim analyses from two…

GUILDFORD, England, May 15, 2023 (GLOBE NEWSWIRE) -- SiSaf Ltd,…

- Granted Orphan Drug Exclusivity through May 1, 2030 -…